IQInvest
Sign in

Tools · AMGN

Amgen Inc., taken apart.

Four panels built from the reported annual accounts, then the rest of the engine. Every figure below is Amgen Inc.’s own filing, not an estimate of ours.

What the analysts say

The published view, for contrast with ours. The source gives a consensus and a target range rather than a full buy/hold/sell breakdown, so that is what is shown — and it is why the grade scores analyst upside rather than counting recommendations.

Published analyst recommendations on Amgen Inc..
Published figurePositionDetail
Consensus: Buy29 analysts
Mean target: $388.4870% of range
High target: $457.00100% of range
Low target: $230.000% of range

29 analysts cover it, and their targets run from $230.00 to $457.00 — a spread of 99%, with the mean 12.4% below today's price. A consensus is an average of disagreement, not a forecast.

The rest of the engine

The panels above are built from filings. These run against the live engine.